ENTA
Enanta Pharmaceuticals Inc
Price:  
15.82 
USD
Volume:  
132,611.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ENTA Relative Valuation

-1257.0%
Upside

As of 2024-07-18, the Relative Valuation of Enanta Pharmaceuticals Inc (ENTA) is (183.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.82 USD, the upside of Enanta Pharmaceuticals Inc based on Relative Valuation is -1257.0%.

The range of the Relative Valuation is (171.68) - (186.86) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 27.6x - 31.1x 30.8x
Forward P/E multiples 25.8x - 30.0x 28.0x
Fair Price (171.68) - (186.86) (183.03)
Upside -1185.2% - -1281.1% -1257.0%
15.82 USD
Stock Price
(183.03) USD
Fair Price

ENTA Relative Valuation - Historical P/E Data

Date P/E
2024-07-17 -2.54
2024-07-16 -2.60
2024-07-15 -2.66
2024-07-12 -2.57
2024-07-11 -2.41
2024-07-10 -2.35
2024-07-09 -2.32
2024-07-08 -2.20
2024-07-05 -2.15
2024-07-03 -2.11
2024-07-02 -2.16
2024-07-01 -2.10
2024-06-28 -2.09
2024-06-27 -2.04
2024-06-26 -1.96
2024-06-25 -1.97
2024-06-24 -1.96
2024-06-21 -1.92
2024-06-20 -1.84
2024-06-18 -1.90
2024-06-17 -1.94
2024-06-14 -2.06
2024-06-13 -2.16
2024-06-12 -2.14
2024-06-11 -2.16
2024-06-10 -2.05
2024-06-07 -2.08
2024-06-06 -2.02
2024-06-05 -1.99
2024-06-04 -1.97
2024-06-03 -1.99
2024-05-31 -2.00
2024-05-30 -1.93
2024-05-29 -1.91
2024-05-28 -1.92
2024-05-24 -1.93
2024-05-23 -1.94
2024-05-22 -2.06
2024-05-21 -2.00
2024-05-20 -2.00
2024-05-17 -1.95
2024-05-16 -2.10
2024-05-15 -2.14
2024-05-14 -2.13
2024-05-13 -2.08
2024-05-10 -2.03
2024-05-09 -2.08
2024-05-08 -2.05
2024-05-07 -2.11
2024-05-06 -2.35